Asset Allocation

As of October 31, 2025.
Type % Net
Cash 1.23%
Stock 23.56%
Bond 71.71%
Convertible 0.00%
Preferred 2.53%
Other 0.97%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.76%    % Emerging Markets: 0.28%    % Unidentified Markets: 0.95%

Americas 93.93%
93.81%
Canada 82.72%
United States 11.09%
0.12%
As of October 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 4.64%
United Kingdom 2.25%
2.22%
Denmark 0.00%
France 0.64%
Germany 0.01%
Ireland 0.20%
Italy 0.17%
Netherlands 0.45%
Sweden 0.73%
Switzerland 0.02%
0.14%
Poland 0.14%
0.01%
Israel 0.01%
Greater Asia 0.48%
Japan 0.34%
0.03%
Australia 0.02%
0.11%
Singapore 0.11%
0.00%
Unidentified Region 0.95%

Bond Credit Quality Exposure

AAA 27.39%
AA 16.69%
A 32.61%
BBB 15.02%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.17%
Not Available 7.12%
Short Term 0.00%
As of October 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
12.99%
Materials
0.22%
Consumer Discretionary
3.68%
Financials
7.09%
Real Estate
2.01%
Sensitive
9.73%
Communication Services
1.05%
Energy
0.00%
Industrials
4.68%
Information Technology
4.00%
Defensive
2.94%
Consumer Staples
1.91%
Health Care
0.52%
Utilities
0.51%
Not Classified
74.33%
Non Classified Equity
0.00%
Not Classified - Non Equity
74.33%
As of October 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of October 31, 2025
Type % Net
Government 14.84%
Corporate 45.45%
Securitized 2.36%
Municipal 27.38%
Other 9.98%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.85%
Less than 1 Year
0.85%
Intermediate
63.94%
1 to 3 Years
10.11%
3 to 5 Years
16.98%
5 to 10 Years
36.85%
Long Term
31.65%
10 to 20 Years
11.70%
20 to 30 Years
16.28%
Over 30 Years
3.67%
Other
3.56%
As of October 31, 2025
View Bond Maturity Exposure
Start Trial